 |
Video: What is a Stock Split?
|
 |
Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Co. is seeking to develop IRX-2, a cytokine-based therapy, to treat patients with cancer. Co. also is exploring opportunities to advance oncology, blood disorder, and monogenic disease therapies using gene-editing and cell therapy technology through a license with Factor Bioscience Limited and through its subsidairies, Novellus, Inc. and Novellus, Ltd. According to our BTX split history records, BTX has had 2 splits. | |
 |

BTX (BTX) has 2 splits in our BTX split history database. The first split for BTX took place on October 31, 1997. This was a 3 for 1
split, meaning for each share of BTX owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split. BTX's second split took place on March 26, 2021. This was a 1 for 2 reverse split, meaning for each 2 shares of BTX owned pre-split, the shareholder now owned 1 share. For example, a 3000 share position pre-split, became a 1500 share position following the split.
When a company such as BTX splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as BTX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the BTX split history from start to finish, an original position size of 1000 shares would have turned into 1500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BTX shares, starting with a $10,000 purchase of BTX, presented on a split-history-adjusted basis factoring in the complete BTX split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/12/2015 |
|
End date: |
10/14/2022 |
|
Start price/share: |
$0.90 |
|
End price/share: |
$0.21 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-76.67% |
|
Average Annual Total Return: |
-17.28% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,333.30 |
|
Years: |
7.67 |
|
|
 |
Date |
Ratio |
10/31/1997 | 3 for 1
| 03/26/2021 | 1 for 2 |
|
 |